ARCHIVES

ODAC Recommends Taxol For Metastatic Breast Cancer

This article is from The Cancer Letter archive.

Vol. 20 No. 01 | January 7, 1994

Download PDF Visit The Full Archive

Related Articles

Advanced Ovarian Cancer Responds To Irofulven In Phase II Studies

October 26, 2001

Varmus Pledges No Funding Gap for NCORP, Blames Snafu On “Unclear Communication”

April 11, 2014

Avastin improves lung cancer survival, opens options for new combinations. Details of Avastin risk vs. benefit to be released at ASCO annual meeting.

April 1, 2005

Minority Trial Participation A Matter of Access, Study Says

December 30, 2005

Congressional Report Days NCI Ignored Data, Procedure, In Changes To Screening Guidelines

November 4, 1994

ASC Survey Leads to Strategic Plan Development, Office In Washington

June 9, 1989